Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma
E Mitry, J Taïeb, P Artru, et al.
Gastroenterologie Clinique Et Biologique
|
October 8, 1998
[Autoimmune cholangitis successfully treated with corticotherapy. One case]
E Mitry, J P Algayres, H Bili, et al.
British Journal of Cancer
|
April 1, 2004
Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001
M P Coleman, B Rachet, L M Woods, et al.
Alimentary Pharmacology & Therapeutics
|
April 28, 2009
Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients
L Abramowitz, N Mathieu, F Roudot-Thoraval, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2008
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations
D Papamichael, R Audisio, J-C Horiot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma
J Taïeb, E Mitry, V Boige, et al.
Cancer Chemotherapy and Pharmacology
|
September 29, 2007
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases
M Ychou, F Viret, A Kramar, et al.
Gastroenterologie Clinique Et Biologique
|
September 18, 2009
Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: feasibility and potential benefits in a retrospective series of 117 patients
J-B Bachet, E Mitry, A Lièvre, et al.
British Journal of Cancer
|
October 1, 2008
Cancer survival in England and Wales at the end of the 20th century
B Rachet, L M Woods, E Mitry, et al.
British Journal of Cancer
|
December 22, 1999
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
E Mitry, E Baudin, M Ducreux, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma
E Mitry, J Taïeb, P Artru, et al.
Gastroenterologie Clinique Et Biologique
|
October 8, 1998
[Autoimmune cholangitis successfully treated with corticotherapy. One case]
E Mitry, J P Algayres, H Bili, et al.
British Journal of Cancer
|
April 1, 2004
Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001
M P Coleman, B Rachet, L M Woods, et al.
Alimentary Pharmacology & Therapeutics
|
April 28, 2009
Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients
L Abramowitz, N Mathieu, F Roudot-Thoraval, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2008
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations
D Papamichael, R Audisio, J-C Horiot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma
J Taïeb, E Mitry, V Boige, et al.
Cancer Chemotherapy and Pharmacology
|
September 29, 2007
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases
M Ychou, F Viret, A Kramar, et al.
Gastroenterologie Clinique Et Biologique
|
September 18, 2009
Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: feasibility and potential benefits in a retrospective series of 117 patients
J-B Bachet, E Mitry, A Lièvre, et al.
British Journal of Cancer
|
October 1, 2008
Cancer survival in England and Wales at the end of the 20th century
B Rachet, L M Woods, E Mitry, et al.
British Journal of Cancer
|
December 22, 1999
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
E Mitry, E Baudin, M Ducreux, et al.
Page
of 6